Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis)
Featured Articles
(Morningstar) Dec 14, 2017 - BioSight Ltd, a pharmaceutical development company, focused on the development of targeted oncology drugs, reports positive final results in a Phase I/II multi-center, open label, dose-escalating study of its lead product BST-236, a novel cytarabine pro-drug, as a single agent for induction therapy in acute...
Read Article
(Markets Insider) Dec 12, 2017 - Servier, Pfizer Inc. and Cellectis presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta preliminary results from two phase 1 studies of UCART19, an investigational allogeneic anti-CD19 CAR T-cell product, in adult and pediatric patients with relapsed or...
Read Article
Latest Articles
December 13, 2017
December 13, 2017
December 12, 2017
December 12, 2017
December 12, 2017
December 12, 2017
December 12, 2017
December 12, 2017
View More
News Commentary
Editor Image
21 Apr, 2017 | by Dean Gesme, MD
This will only determine how much delay is allowed by the courts and how...
View Comment
Editor Image
26 Apr, 2017 | by Howard S. Hochster, MD
Fascinating legal wrangling as the Supremes parse the wording of the BPCIA...
View Comment
View More
OBR Green
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) OBR Green articles.
OBR Blog
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) blog entries.